NCT00179062View on ClinicalTrials.gov

Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

NACompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

SchizophreniaSchizoaffective DisorderDepressive Disorder, MajorBipolar Disorder

Interventions

DRUG

olanzapine versus risperidone

Participants are to be randomized to olanzapine or risperidone. Antipsychotic medication will be given as per package insert daily for the twelve month duration of the trial.

Trial Locations (1)

37212

Psychiatric Hospital at Vanderbilt, Nashville

All Listed Sponsors

lead

Vanderbilt University

OTHER

NCT00179062 - Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder | Biotech Hunter | Biotech Hunter